Search All UT System Experts

The effect of basal–bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis

S. Heller, K. Bowering, Philip Raskin, A. Liebl, K. Buchholtz, A. Gorst-Rasmussen, T. R. Pieber

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'The effect of basal–bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences